International Clinical Trial: Research on the Combined Prediction of Molecular Typing of Breast Cancer by Ultrasound Artificial Intelligence

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118205) titled 'Research on the Combined Prediction of Molecular Typing of Breast Cancer by Ultrasound Artificial Intelligence' on Feb. 3.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Gongli Hospital of Shanghai Pudong New Area

Condition: Luminal A breast cancer, Luminal B breast cancer, HER2-positive breast cancer, triple-negative breast cancer

Intervention: Gold Standard:Immunohistochemistry (estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 proliferation index)

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025...